List of SBIR/STTR awards granted to Dignify Therapeutics
Dignify TherapeuticsName | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to Dignify Therapeutics in March, 2020 for $1,823,630.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4U44NS106685-02 | Phase II | 1,823,630 | March 1, 2020 | |||||||
A SBIR Phase II contract was awarded to Dignify Therapeutics in September, 2020 for $941,206.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44NS115169-02 | Phase II | 941,206 | September 30, 2020 | |||||||
A STTR Phase I contract was awarded to Dignify Therapeutics in September, 2019 for $269,371.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS115169-01 | Phase I | 269,371 | September 30, 2019 | |||||||
A SBIR Phase I contract was awarded to Dignify Therapeutics in February, 2019 for $901,425.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1U44NS106685-01A1 | Phase I | 901,425 | February 1, 2019 | |||||||
A SBIR Phase I contract was awarded to Dignify Therapeutics in September, 2020 for $244,124.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DK125131-01A1 | Phase I | 244,124 | September 21, 2020 | |||||||
A SBIR Phase I contract was awarded to Dignify Therapeutics in September, 2019 for $299,648.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43NS115215-01 | Phase I | 299,648 | September 30, 2019 | |||||||
A SBIR Phase II contract was awarded to Dignify Therapeutics in May, 2018 for $1,999,992.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 4R44DK112437-02 | Phase II | 1,999,992 | May 1, 2018 | |||||||
A STTR Phase I contract was awarded to Dignify Therapeutics in September, 2020 for $394,754.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41NS117205-01 | Phase I | 394,754 | September 1, 2020 | |||||||
A SBIR Phase I contract was awarded to Dignify Therapeutics in August, 2017 for $300,000.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R44DK112437-01A1 | Phase I | 300,000 | August 7, 2017 | |||||||
A SBIR Phase I contract was awarded to Dignify Therapeutics in September, 2017 for $299,989.0 USD from the U.S. Department of Health & Human Services. | SBIR | 1R43AG057243-01 | Phase I | 299,989 | September 1, 2017 |
